Cynthia E. Keen

ECR 2025
CT lung screening enthusiasts tackle logistical issues
How to minimize harm and maximize benefits from CT lung cancer screening reporting is a major obective and urgent priority, expert speakers said at ECR 2025.
March 4, 2025
Prof. Mathias Prokop. All images courtesy of ESR and Sebastian Kreuzberger.
Digital X-Ray
Is x-ray technology alive? Most definitely yes!
Is x-ray technology still alive, or is it ready for retirement? In a special session held at ECR 2024, Prof. Dr. Ernst Rummeny announces, "X-ray is more alive than ever!"
March 4, 2024
Human Body Xray
Digital X-Ray
Can chest x-ray with AI compete with chest CT?
Chest x-ray is at risk of being rendered obsolete by chest CT scans. But could integrating it with AI allow the modality to hold its own?
March 1, 2024
Chest X Ray Lateral View
Page 1 of 1
Top Stories
Lungs Red 400
Radiation Oncology/Therapy
Radical radiotherapy use rising for treating lung cancer
Radical radiotherapy use nearly doubled between 2010 and 2021 in lung cancer patients and correlates to improved five-year outcomes.
CIRSE 2026
Interventional
CIRSE: Should drug-coated devices remain routine in leg artery treatment?
Endovascular splenorenal shunt in chronic portal vein thrombosis presented by Dr. Carolin Sobotta University Medicine Goettingen Goettingen, Germany
Interventional
CIRSE’s ‘Amazing Interventions’ go beyond conventional routes
Eshnr 26 Promo Ppt Reg Now 1920x1080 V1 Red
MRI
ESHNR heads to Budapest with dental imaging, cancer updates and AI on the agenda
20260905 081521 Art6424 Scaled
Interventional
CIRSE: Patient selection drives local treatment of lung tumours
More in Home
Radical radiotherapy use rising for treating lung cancer
By Amerigo Allegretto
Radical radiotherapy use nearly doubled between 2010 and 2021 in lung cancer patients and correlates to improved five-year outcomes.
September 10, 2026
Lungs Red 400
CIRSE: Should drug-coated devices remain routine in leg artery treatment?
By Claudia Tschabuschnig
Could SWEDEPAD, two Swedish trials comparing drug-coated and uncoated devices for leg artery treatment, change practice? CIRSE experts debated patient benefits and long-term safety.
September 10, 2026
CIRSE 2026
CIRSE’s ‘Amazing Interventions’ go beyond conventional routes
By Claudia Tschabuschnig
From creating new biliary pathways to targeting elusive lymphatic leaks, specialists at CIRSE 2026 shared inventive interventions for patients with few remaining options.
September 9, 2026
Endovascular splenorenal shunt in chronic portal vein thrombosis presented by Dr. Carolin Sobotta University Medicine Goettingen Goettingen, Germany
ESHNR heads to Budapest with dental imaging, cancer updates and AI on the agenda
By Claudia Tschabuschnig
From dental MRI to imaging after cancer treatment, ESHNR 2026 brings practical challenges and emerging techniques to Budapest on September 10–12. Here’s what to watch for.
September 9, 2026
Eshnr 26 Promo Ppt Reg Now 1920x1080 V1 Red
CIRSE: Patient selection drives local treatment of lung tumours
By Claudia Tschabuschnig
Billed as a controversy session, a discussion of local treatments for lung tumors at CIRSE 2026 highlighted common ground: patient selection, lung preservation, and the complementary roles of radiotherapy and ablation.
September 8, 2026
20260905 081521 Art6424 Scaled
Video: Charles Kahn on keeping pace with radiology AI
By Claudia Tschabuschnig
Dr. Charles Kahn looks beyond the AI hype to examine scientific rigor, better publishing, and what comes next.
September 7, 2026
Ck
Attack severely damages diagnostic imaging center in Odesa
By Claudia Tschabuschnig
After its facility was hit on 2 September, Innova Diagnostica is assessing whether its MRI scanner can be saved and working to restore specialized imaging services.
September 4, 2026
The exterior of Innova Diagnostica shows shattered windows, exposed wiring, damaged air-conditioning units, and debris surrounding the building. Several ground-floor windows have been boarded up. A message painted on the facade reads, “They destroy the future. We help bring it to life.”
MRI-based model shows changes over time in multiple myeloma patients
By Amerigo Allegretto
Whole-body MRI could serve as a scalable biomarker for risk stratification in multiple myeloma patients.
September 4, 2026
Multiple Myeloma 400
What should we teach radiology residents now that the algorithm reads too?
By Dr. Filippo Pesapane
In a new column, Dr. Filippo Pesapane of the European Institute of Oncology (IEO) IRCCS in Italy reflects on the important lessons learned about breast imaging AI technology and how they should impact radiologist training.
September 4, 2026
Filippo Pesapane
MRI shows how hormones affect mood
By Amerigo Allegretto
MRI scans show how higher progesterone levels indicate lower mood.
September 2, 2026
Woman Mother Stressed 400
What to watch for at CIRSE 2026
By Claudia Tschabuschnig
The program spans new treatments, clinical practice, training, and access to IR across Europe.
September 2, 2026
Cirse2025
Q&A with Ken Herrmann: Theranostics must move earlier and beyond established targets
By Claudia Tschabuschnig
Prof. Ken Herrmann discusses the expansion of radioligand therapy into earlier treatment lines, the need for new cancer targets, long-term safety, and the challenge of translating innovation into robust clinical evidence.
September 1, 2026
Prof. Ken Herrmann, director of the Department of Nuclear Medicine at University Hospital Essen, pictured fourth from the left, at the opening opening of a new nuclear medicine center in Essen, Germany, focused on theranostics and personalized cancer care.
Page 1 of 92
Next Page